Latest Updates on COVID-19 Testing - Kits, Products, Service

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

« Previous article
Special Focus on Wha...

Next article »
Latest Updates on CO...

20th October 2020 Content supplied by: rapidmicrobiology.com

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 20 Oct 2020

In this week's COVID-19 updates: The company who gave the world the one-minute HIV test, now does it again for COVID-19 antibody testing; finding RNA extraction cumbersome? Look at Alpha Laboratories' offerings of semi- and fully-automated instruments; A new FDA authorized rapid test for Influenza A & B and COVID-19 for point-of-care diagnosis; Creative Diagnostics showcase their new collection of SARS-CoV-2 immunoassay kits for research-use-only; US Gov gives a financial boost to Cue Health to start rolling out millions of its rapid test and the emergency authorization and distribution of SARS-CoV-2 begins in China.

New CE-Marked COVID-19 Antibody Test Delivers Results in One Minute

bioLytical Laboratories has obtained CE-Marking for its one-minute COVID-19 total antibody test. The test detects IgA, IgG and IgM SARS-CoV-2 antibodies in a patient's whole blood, serum or plasma sample.
Find Out More

New QuickGene Range for DNA & RNA Extraction - Now with Automated Option

Improve workflow and remove the danger of unbalanced centrifuges and the hassle of overbooked machines with QuickGene semi- and fully-automated DNA & RNA extraction instruments. Perfect for PCR Testing or other downstream applications.
Find Out More

FDA Authorizes Point-of-Care Rapid Antigen Test for COVID-19 & Influenza A/B

US FDA has authorized a three-way rapid antigen test that can simultaneously detect SARS-CoV-2 and Influenza A & B in 15 minutes. Quidel's Sofia® 2 Flu + SARS Antigen FIA claims high diagnostic accuracy in patients within the first 5 days of the onset of symptoms.
Find Out More

Creative Diagnostics Launches SARS-CoV-2 Immunoassay Kits for Researchers

Creative Diagnostics introduces SARS-CoV-2 immunoassay kits for direct detection of SARS-CoV-2 antigens and antibodies. This kit is for Research Use Only (RUO).
Find Out More

US Contract Sees Deployment of Six Million Rapid COVID-19 Tests by March 2021

Cue Health will begin manufacturing and deploying six million of its Cue COVID-19 point of care test after been awarded $481 Million from the US Department of Defense (DOD). The test is an isothermal nucleic acid amplification, providing results within 20 minutes to a smartphone.
Find Out More

Medical Product Designer Becomes China SARS-CoV-2 Vaccine Distributor

Pacific Providence has announced they have expanded their business to be worldwide representatives and distributors for the CNBG/Sinopharm COVID-19 vaccine, which has been released under emergency use and is planned to be officially available for the end of 2020.
Find Out More

Tags: